Rigel Pharmaceuticals (NASDAQ:RIGL) Earns Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) in a report released on Wednesday morning,Benzinga reports. HC Wainwright currently has a $57.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Rigel Pharmaceuticals’ Q1 2025 earnings at ($0.07) EPS, Q2 2025 earnings at $0.12 […]
HC Wainwright reissued their buy rating on shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) in a report released on Wednesday morning,Benzinga reports. HC Wainwright currently has a $57.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Rigel Pharmaceuticals’ Q1 2025 earnings at ($0.07) EPS, Q2 2025 earnings at $0.12 […]
